by Indigo | Jan 11, 2020 | 2020, News
Indigo will be present during the J.P. Morgan 2020 Healthcare conference on January 13-16 in San Francisco, USA. If you are interested to talk to us, we will be delighted to meet you. Please contact us info@indigomed.com (+32 475 41 21 32)
by Indigo | Nov 22, 2019 | 2019, News
Indigo Diabetes NV, a medical device company creating next-gen sensors for diabetes healthcare, today announced it has received ISO 13485 certification from TÜV Süd for the Design and Development of Biomarker Sensing Devices and Services. This certification confirms...
by Indigo | May 23, 2019 | 2019, News
clinical study “action-1” kicked-off: T1D IN ACTION FOR KETONES AND LACTATE Indigo is pleased to announce that our clinical study “Action-1” kicked-off. The first patient has now been enrolled into “Action-1”, our prospective,...
by Indigo | Dec 15, 2018 | 2018, Archive
We are extremely proud to announce the opening of our new lab in Ghent! We spent a couple of months building up a lab that provides all necessary equipment for our research and development. This is a huge improvement for our team. At Indigo we are committed to making...
by Indigo | Dec 1, 2018 | 2018, Archive
Flanders Innovation and Entrepreneurship rewards Indigo a grant to support the development of its next generation CGM device December 1, 2018 Flanders Innovation & Entrepreneurship (Vlaio) stimulates innovation in Flanders and therefore finances research and...
